Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Randomized Control Trial	STARTED	Fesoterodine	322
Randomized Control Trial	STARTED	Placebo	323
Randomized Control Trial	COMPLETED	Fesoterodine	284
Randomized Control Trial	COMPLETED	Placebo	284
Randomized Control Trial	NOT COMPLETED	Fesoterodine	38
Randomized Control Trial	NOT COMPLETED	Placebo	39
Open-label Follow-up	STARTED	Fesoterodine	268
Open-label Follow-up	STARTED	Placebo	274
Open-label Follow-up	COMPLETED	Fesoterodine	229
Open-label Follow-up	COMPLETED	Placebo	225
Open-label Follow-up	NOT COMPLETED	Fesoterodine	39
Open-label Follow-up	NOT COMPLETED	Placebo	49

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00862745/flow